Cargando…

New Hopes for Treatment of Alzheimer’s Disease

Detalles Bibliográficos
Autor principal:	Akhondzadeh, Shahin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Avicenna Research Institute 201
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742647/ https://www.ncbi.nlm.nih.gov/pubmed/29296259

Ejemplares similares

Medical Biotechnology and Alzheimer’s Disease: New Hopes
por: Akhondzadeh, Shahin
Publicado: (2016)

Research in Iran: Hopes and Disappointments
por: Akhondzadeh, Shahin
Publicado: (2017)

New drug discovery for Alzheimer's disease: Challenges and hopes
por: Sathyanarayana Rao, T. S., et al.
Publicado: (2009)

Monoclonal Antibody a Promising Treatment for Depression
por: Akhondzadeh, Shahin
Publicado: (2019)

Anti-amyloid agents for treating incipient Alzheimer’s disease: a new hope?
por: Loureiro, Julia C., et al.
Publicado: (2022)

New treatment strategies for Alzheimer's disease: is there a hope?
por: Aprahamian, Ivan, et al.
Publicado: (2013)

Immunotherapy in Thoracic Malignancies: New Treatment and New Hope
por: Melosky, Barbara
Publicado: (2022)

New targets, new hopes
por: Strijbos, M., et al.
Publicado: (2022)

Ethical Issues in Medical Biotechnology
por: Akhondzadeh, Shahin
Publicado: (2014)

Iranian science shows world's fastest growth: ranks 17th in science production in 2012
por: Akhondzadeh, Shahin
Publicado: (2013)

Avicenna and Evidence Based Medicine
por: Akhondzadeh, Shahin
Publicado: (2014)

The Importance of Ethics in Medical Biotechnology
por: Akhondzadeh, Shahin
Publicado: (2015)

The Economic Aspects of Medical Biotechnology
por: Akhondzadeh, Shahin
Publicado: (2016)

Autistic Disorders and Medical Biotechnology
por: Akhondzadeh, Shahin
Publicado: (2015)

Personalized Medicine: A Tailor Made Medicine
por: Akhondzadeh, Shahin
Publicado: (2014)

US Editors and Reviewers can no Longer Handle Submissions by Authors Employed by the Government of Iran: Is it Fair and Logical?
por: Akhondzadeh, Shahin
Publicado: (2013)

Evidence Based Medicine and Medical Biotechnology
por: Akhondzadeh, Shahin
Publicado: (2015)

The Importance of Clinical Trials in Drug Development
por: Akhondzadeh, Shahin
Publicado: (2016)

Research Institutions without Walls
por: Akhondzadeh, Shahin
Publicado: (2014)

Monoclonal Antibody for Reducing Memory and Learning Problems in Schizophrenia
por: Akhondzadeh, Shahin
Publicado: (2018)

Depression and Inflammation: Is There any Role for Biomarkers?
por: Akhondzadeh, Shahin
Publicado: (2019)

Innovation and Technology in Iran
por: Akhondzadeh, Shahin
Publicado: (2017)

Research in Iran: An Overview
por: Akhondzadeh, Shahin
Publicado: (2017)

Microbiota and Autism Spectrum Disorder
por: Akhondzadeh, Shahin
Publicado: (2019)

Microbiome and Schizophrenia
por: Akhondzadeh, Shahin
Publicado: (2019)

Repositioning Drugs for Psychiatry
por: Akhondzadeh, Shahin
Publicado: (2020)

Parkinson’s disease: no NOP, new hope
por: Arcuri, Ludovico, et al.
Publicado: (2016)

Neurodegenerative disease: models, mechanisms, and a new hope
por: Gitler, Aaron D., et al.
Publicado: (2017)

Basic Science and Clinical Studies on Non-COVID-19 Topics, of Coronavirus Victims
por: Akhondzadeh, Shahin, et al.
Publicado: (2021)

Medical Biotechnology in the Service of Coronavirus Vaccine Discovery and Production
por: Akhondzadeh, Shahin, et al.
Publicado: (2021)

Coronavirus Vaccination and Mortality in the Omicron Outbreak in Iran: Mortality Reduction due to Attenuated Pathogenicity and Booster Vaccine Doses
por: Shamabadi, Ahmad, et al.
Publicado: (2022)

Protection against the Omicron and Subsequent Coronavirus Variants: Medical-grade Masking, Third Dose Vaccination, Updating Vaccines, and Pursuing Universal Vaccine
por: Shamabadi, Ahmad, et al.
Publicado: (2022)

The Requisiteness for not Sacrificing Medical Biotechnology in the Coronavirus Era
por: Akhondzadeh, Shahin, et al.
Publicado: (2021)

Monkeypox Outbreaks in Non-Endemic Countries: What Do We Know and What Do We Need?
por: Shamabadi, Ahmad, et al.
Publicado: (2022)

Inflammation-Schizophrenia: A Bidirectional Causal Association Mediated by Cytokines
por: Shamabadi, Ahmad, et al.
Publicado: (2023)

A New Era of Hope for the World's Most Neglected Diseases
Publicado: (2005)

The New Journal, Hopes and Aims for the Future
Publicado: (1990)

Interdisciplinary Collaboration between Bench and Bedside in the COVID-19 Pandemic
por: Sanjari Moghaddam, Hossein, et al.
Publicado: (2023)

The Clinician Scientist Training Program in Iran: Catalyzing Clinical Science Advancements
por: Sanjari Moghaddan, Hosseein, et al.
Publicado: (2023)

New Hopes for the Treatment of Primary Ovarian Insufficiency/Premature Ovarian Failure
por: Sadeghi, Mohammad Reza
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hol6rknolsju01qdeeeo0l2ga1